Diagnostic anti-[West Nile virus (WNV)] antibodies pairs for testing in ELISA, Lateral flow immunoassay (LFIA) and other immunoassays for West Nile fever.

West Nile virus (WNV) is the leading cause of mosquito-borne disease in the continental United States. It is most commonly spread to people by the bite of an infected mosquito. Cases of WNV occur during mosquito season, which starts in the summer and continues through fall. There are no vaccines to prevent or medications to treat WNV in people. Fortunately, most people infected with WNV do not feel sick. About 1 in 5 people who are infected develop a fever and other symptoms. About 1 out of 150 infected people develop a serious, sometimes fatal, illness. You can reduce your risk of WNV by using insect repellent and wearing long-sleeved shirts and long pants to prevent mosquito bites.Genemedi produces core diagnostic ingredients-validated antibodies pairs Mouse anti-West Nile virus (WNV) monoclonal antibody for rapid test kit of West Nile fever (WNV) to evaluate the related human infectious disease.The paired antibodies are both monoclonal antibody(mab).

All the antibodies and antiges of animal disease test are suitable for in functional ELISA, and other immunoassays in diagnostics.The antibody can act as a capture antibody and detection antibody. Antigens are validated as positive control materials.

Order information

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-WNV-1Ab-1mg	1mg	1953
GMP-WNV-1Ab-10mg	10mg	13671
GMP-WNV-1Ab-100mg	100mg	95697
GMP-WNV-1Ab-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Antigen & Antibody Name	Mouse anti-West Nile virus (WNV) monoclonal antibody
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Antibody Binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays in[West Nile virus (WNV)] level test in human infectious disease diagnositcs-for West Nile fever.
Tag	mFc
Products description	West Nile virus (WNV) is the leading cause of mosquito-borne disease in the continental United States. It is most commonly spread to people by the bite of an infected mosquito. Cases of WNV occur during mosquito season, which starts in the summer and continues through fall. There are no vaccines to prevent or medications to treat WNV in people. Fortunately, most people infected with WNV do not feel sick. About 1 in 5 people who are infected develop a fever and other symptoms. About 1 out of 150 infected people develop a serious, sometimes fatal, illness. You can reduce your risk of WNV by using insect repellent and wearing long-sleeved shirts and long pants to prevent mosquito bites.
Purity	Purity: ≥95% (SDS-PAGE)
Application	ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.